- Study type: Randomised Clinical Trial, Prevention
- Study type descriptors: Randomised controlled trial, Multicentre
- Objective: To evaluate the safety and immunogenicity of a booster dose of an intranasal COVID-19 vaccine (LVt-001) versus a booster dose of a COVID-19 mRNA vaccine (Pfizer-BioNTech) in healthy adult volunteers
- Number of participants enrolled: Enrollment ongoing
- Study enrolling from to
- Study includes follow-up for 1 year
Study Data
- Adults (18-64 years)
- General population
- Hospital
- Outpatient clinic
- SARS-CoV-2
- Pharmacological intervention
- Vaccination
External Links
Other information
If you would like to contact the Principal Investigator of the study please email: ccb@ateneo.univr.it
The data is updated up to